Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Year-over-year total asset growth rate
Latest
-22.16%
↓ 165% vs avg
Percentile
P3
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
34.33%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -22.16% |
| Q3 2025 | 24.91% |
| Q2 2025 | -11.86% |
| Q1 2025 | -15.01% |
| Q4 2024 | -8.58% |
| Q3 2024 | -7.65% |
| Q2 2024 | -4.45% |
| Q1 2024 | 158.72% |
| Q4 2023 | -7.71% |
| Q3 2023 | -6.95% |
| Q2 2023 | -6.05% |
| Q1 2023 | -5.93% |
| Q4 2022 | -4.97% |
| Q3 2022 | 111.63% |
| Q2 2022 | -11.75% |
| Q1 2022 | -9.46% |
| Q4 2021 | -10.54% |
| Q3 2021 | 8.66% |
| Q2 2021 | -13.00% |
| Q1 2021 | -11.14% |
| Q4 2020 | -8.14% |
| Q3 2020 | -9.17% |
| Q2 2020 | 70.22% |
| Q1 2020 | 1317.07% |
| Q4 2019 | -94.40% |
| Q3 2019 | -10.59% |
| Q2 2019 | -5.72% |
| Q1 2019 | -9.51% |
| Q4 2018 | -7.72% |
| Q3 2018 | 65.34% |
| Q2 2018 | -13.84% |
| Q1 2018 | -12.22% |
| Q4 2017 | 9.60% |
| Q3 2017 | -11.56% |
| Q2 2017 | -8.82% |
| Q1 2017 | -9.31% |
| Q4 2016 | -7.77% |
| Q3 2016 | -7.82% |
| Q2 2016 | -8.94% |
| Q1 2016 | -10.09% |